The global gamma camera market will experience accelerated growth pending the availability of new diagnostic or therapeutic agents and clinical adoption of hybrid SPECT-CT imaging systems, according to a new report by market research firm Frost & Sullivan called "Strategic Analysis of Global Gamma Camera Markets."
Although the global gamma camera market seems like a very mature market now, its great promise lies in the fact that it is a key modality of molecular imaging, says Frost & Sullivan.
The report estimates the global gamma camera market generated revenues of $638.0 million in 2003. The market is expected to grow at a compound annual growth rate of 3.1 percent to $788.8 million in 2010.
The report says in the short term the market will be constrained by the lack of new imaging agents that can open up new clinical applications, and by competition for budget and resources from positron emission tomography (PET).
In the long-run, compared with PET imaging, nuclear gamma cameras' key competitive advantages lie in its much larger worldwide installed base and the availability of longer half-life radioisotopes, says the report.